Keywords: glivec, gets, chmp, nod, new, indication, swiss

Glivec gets CHMP nod for new indication

Article | 30 March 2009

Print This

Swiss drug major Novartis has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in